首页|间充质干细胞治疗造血干细胞移植后移植物抗宿主病的增效策略研究进展

间充质干细胞治疗造血干细胞移植后移植物抗宿主病的增效策略研究进展

扫码查看
间充质干细胞(MSC)具有独特的免疫调节特性,在治疗移植物抗宿主病(GVHD)方面具有较大的潜力.然而,MSC体内植入率和存活率低,免疫抑制能力弱,导致临床应用MSC治疗GVHD时疗效不够稳定.对MSC进行低氧预处理、活性分子预处理和基因修饰可增强MSC的功能,提升MSC的植入率、存活率和治疗效果.本文就近年来MSC治疗造血干细胞移植并发GVHD的增效策略的最新研究进展作一综述,旨在为优化MSC在防治GVHD中的应用提供新策略.
Research Advances in Strategies to Enhance the Therapeutic Effects of Mesenchymal Stem Cells on Graft-Versus-Host Disease Post Hematopoietic Stem Cell Transplantation——Review
Mesenchymal stem cells (MSC) possess unique immunomodulatory properties and have enormous potential in the treatment of graft-versus-host disease (GVHD). However,the low implantation and survival rates of MSC in vivo,coupled with their weak immunosuppressive functions,have resulted in unstable clinical efficacy in the treatment of GVHD. Preconditioning of MSC with hypoxia,active molecules and gene modification can enhance the function of MSC and improve the implantation rate,survival rate and therapeutic effect of MSC. This review summarized the strategies for enhancing the efficacy of MSC in the treatment of hematopoietic stem cell transplantation complicated with GVHD in recent years,aiming to provide new strategies for optimizing the application of MSC in the prevention and treatment of GVHD.

hematopoietic stem cell transplantationgraft-versus-host diseasemesenchymal stem cellsstrategies for enhancing the efficacy

许润香、李佩霖、朱恒、丁丽

展开 >

空军军医大学研究生院,陕西西安 710032

空军特色医学中心血液科,北京 100142

北京辐射医学研究所,北京 100850

安徽医科大学基础医学院,安徽合肥 230032

河北北方学院研究生院,河北张家口 075000

展开 >

造血干细胞移植 移植物抗宿主病 间充质干细胞 增效策略

2024

中国实验血液学杂志
中国病理生理学会

中国实验血液学杂志

CSTPCD北大核心
影响因子:0.988
ISSN:1009-2137
年,卷(期):2024.32(6)